277
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Therapeutic inertia: a retrospective examination of inpatient management for type 2 diabetes mellitus at a South African regional hospital during a singular hospitalisation

&
Pages 24-29 | Received 14 Oct 2023, Accepted 19 Jan 2024, Published online: 24 Feb 2024

References

  • Stone MA, Charpentier G, Doggen K, et al. Quality of care of people with type 2 diabetes in eight European countries. Diabetes Care. 2013;36(9):2628–2638. https://doi.org/10.2337/dc12-1759
  • de Pablos-Velasco P, Parhofer KG, Bradley C, et al. Current level of glycaemic control and its associated factors in patients with type 2 diabetes across Europe: data from the PANORAMA study. Clin Endocrinol (Oxf). 2014;80(1):47–56. https://doi.org/10.1111/cen.12119
  • Okonofua EC, Simpson KN, Jesri A, Rehman SU, Durkalski VL, Egan BM. Therapeutic inertia is an impediment to achieving the healthy people 2010 blood pressure control goals. Hypertension. 2006;47(3):345-351. https://doi.org/10.1161/01.HYP.0000200702.76436.4b.
  • Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28(2):103–117. https://doi.org/10.1016/0168-8227(95)01064-K
  • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837–53. Erratum in: Lancet 1999;354(9178):602. https://doi.org/10.1016/S0140-6736(98)07019-6
  • Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560–2572. https://doi.org/10.1056/NEJMoa0802987
  • Chew EY, Ambrosius WT, Davis MD, et al. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med. 2010;363(3):233–244. https://doi.org/10.1056/NEJMoa1001288
  • Duckworth W, Abraira C, Moritz T, et al. VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360(2):129–139. https://doi.org/10.1056/NEJMoa0808431
  • Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Br Med J. 2000;321(7258):405–412. https://doi.org/10.1136/bmj.321.7258.405
  • Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–1589. https://doi.org/10.1056/NEJMoa0806470
  • Skovlund S, Peyrot M. The diabetes attitudes, wishes, and needs (DAWN) program: a new approach to improving outcomes of diabetes care. Diabetes Spectr. 2005;18(3):136–142. https://doi.org/10.2337/diaspect.18.3.136
  • Khunti K, Wolden ML, Thorsted BL, Andersen M, Davies MJ. Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people. Diabetes Care. 2013;36(11):3411–3417. https://doi.org/10.2337/dc13-0331
  • Knecht LA, Gauthier SM, Castro JC, et al. Diabetes care in the hospital: is there clinical inertia? J Hosp Med. 2006;1(3):151–160. https://doi.org/10.1002/jhm.94
  • Ngassa Piotie P, Webb EM, Rheeder P. Suboptimal control for patients with type 2 diabetes in the central chronic medicine dispensing programme in South Africa. Afr J Prim Health Care Fam Med. 2021;13(1):e1–e7. https://doi.org/10.1071/HCv13n1_ED1
  • Pinchevsky Y, Butkow N, Chirwa T, et al. Glycaemic, blood pressure and cholesterol control in 25 629 diabetics. Cardiovasc J Afr. 2015;26(4):188–192. https://doi.org/10.5830/CVJA-2015-050
  • Govender R, Gathiram P, Panajatovic M. Poor control and management of type 2 diabetes mellitus at an under-resourced South African hospital: is it a case of clinical inertia? S Afr Fam Pract. 2017;59(5):154–159. https://doi.org/10.1080/20786190.2017.1307909
  • The Society for Endocrinology, Metabolism and Diabetes of South Africa Type 2 Diabetes Guidelines Expert Committee. The 2017 SEMDSA guideline for the management of type 2 diabetes guideline committee. JEMDSA. 2017;21(1)(Supplement 1):S1–S196. https://doi.org/10.10520/EJC-1005543282.
  • Shah BR, Hux JE, Laupacis A, et al. Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians? Diabetes Care. 2005;28(3):600–606. https://doi.org/10.2337/diacare.28.3.600
  • Mata-Cases M, Franch-Nadal J, Real J. Therapeutic inertia in patients treated with two or more antidiabetics in primary care: factors predicting intensification of treatment. Diabetes Obes Metab. 2018;20:103–112. https://doi.org/10.1111/dom.13045.
  • Umpierrez GE, Reyes D, Smiley D, Hermayer K, Khan A, Olson DE, Pasquel F, Jacobs S, Newton C, Peng L, Fonseca V. Hospital discharge algorithm based on admission HbA1c for the management of patients with type 2 diabetes. Diabetes Care. 2014;37(11):2934–2939. https://doi.org/10.2337/dc14-0479
  • Lysy Z, Fung K, Giannakeas V, et al. The association between insulin initiation and adverse outcomes after hospital discharge in older adults: a population-based cohort study. J Gen Intern Med. 2019;34:575–582. https://doi.org/10.1007/s11606-019-04849-3
  • Anderson TS, Lee AK, Jing B, et al. Intensification of diabetes medications at hospital discharge and clinical outcomes in older adults in the veterans administration health system. Jama Netw Open. 2021;4(10):e2128998. https://doi.org/10.1001/jamanetworkopen.2021.28998
  • Wan KS, Moy FM, Yusof M, et al. Clinical inertia in type 2 diabetes management in a middle-income country: A retrospective cohort study. PLoS ONE. 2020;15(10):e0240531. https://doi.org/10.1371/journal.pone.0240531
  • Khunti K, Nikolajsen A, Thorsted BL, Andersen M, Davies MJ, Paul SK. Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin. Diabetes Obes Metab. 2016;18(4):401–409. https://doi.org/10.1111/dom.12626
  • Khunti K, Gomes MB, Pocock S, et al. Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review. Diabetes Obes Metab. 2018;20:427–437. https://doi.org/10.1111/dom.13088
  • Pantalone KM, Wells BJ, Chagin KM, et al. Intensification of diabetes therapy and time until A1C goal attainment among patients with newly diagnosed type 2 diabetes who fail metformin monotherapy within a large integrated health system. Diabetes Care. 2016;39(9):1527–1534. https://doi.org/10.2337/dc16-0227
  • Laura N, McEwen LN, Dori Bilik D, Susan L, Johnson SL, et al. Predictors and impact of intensification of antihyperglycemic therapy in type 2 diabetes: translating research into action for diabetes (TRIAD). Diabetes Care. 2009;32(6):971–976. https://doi.org/10.2337/dc08-1911
  • Smith SC, David Haslam D. Abdominal obesity, waist circumference and cardio-metabolic risk: awareness among primary care physicians, the general population and patients at risk – the shape of the nations survey. Curr Med Res Opin. 2007;23(1):29–47. https://doi.org/10.1185/030079906X159489
  • ElSayed NA, Aleppo G, Aroda VR, et al., American diabetes association. comprehensive medical evaluation and assessment of comorbidities: standards of care in diabetes—2023. Diabetes Care. 2023;46(Suppl. 1):S49–S67.2. https://doi.org/10.2337/dc23-S004
  • Department of Health. An organisation with a memory. Report of an expert group on learning from adverse events in the NHS. London: The Stationery Office, 2000.
  • Institute of Medicine. To err is human: building a safer health system. Report of the committee on quality of health care in America. Washington: National Academy Press; 2000.
  • Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients. Results of the Harvard medical practice study II. N Engl J Med. 1991;324:377–384. https://doi.org/10.1056/NEJM199102073240605.
  • Barber ND, Dean BS. The incidence of medication errors and ways to reduce them. Clin Risk. 1998;4:103–106. https://doi.org/10.1177/135626229800400401
  • Pote S, Tiwari P, D’Cruz S. Medication prescribing errors in a public teaching hospital in India: a prospective study. Pharm Pract. 2007;5(1):17–20. https://doi.org/10.4321/s1886-36552007000100003.
  • Malangu N, Nchabeleng SD. Impact of prescribing and dispensing errors in patients on antiretroviral treatment in South Africa. AJPP. 2012;6(18):1337–1340. https://doi.org/10.5897/AJPP10.190
  • Valley M. Prescribing errors at an academic teaching hospital in Johannesburg; 2017. https://api.semanticscholar.org/CorpusID:79616818
  • Adebusoye LA, Kalula SZ. Mortality among older patients admitted to the medical wards of Groote Schuur Hospital, Cape Town, South Africa, 2010–2013. S Afr Med J. 2019;109(2):116–121. https://doi.org/10.7196/SAMJ.2019.v109i2.13275.
  • Overcoming Therapeutic Inertia [homepage on the Internet]. Arlington: American Diabetes Association; c2023. Available from: https://www.therapeuticinertia.diabetes.org/ Accessed 13 September 2023.